Samples
Manage and track biological samples across studies
Total Samples
930
Cell Types
19
Conditions
19
Studies
42
Filters
Sample Data
Showing 50 of 930 samples| NAME | SUBJECT ID | CELL TYPE | CONDITION | ASSAYS | COLLECTION DATE | ACTIONS | |
|---|---|---|---|---|---|---|---|
|
HTO3-HD-3536-V3D163-PC
|
3536
|
Plasma cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V3D178-PC
|
407
|
Plasma cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V3D177-PC
|
3001
|
Plasma cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V3D182-PC
|
3338
|
Plasma cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V3D190-BN
|
2644
|
B Naive | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V3D152-BN
|
2583
|
B Naive | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V3D163-BN
|
3536
|
B Naive | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V3D178-BN
|
407
|
B Naive | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V3D177-BN
|
3001
|
B Naive | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V3D182-BN
|
3338
|
B Naive | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V3D190-27
|
2644
|
CD27+ cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V3D152-27
|
2583
|
CD27+ cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V3D163-27
|
3536
|
CD27+ cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V3D178-27
|
407
|
CD27+ cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V3D177-27
|
3001
|
CD27+ cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V3D182-27
|
3338
|
CD27+ cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V3D190-DN
|
2644
|
DN B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V3D152-DN
|
2583
|
DN B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V3D163-DN
|
3536
|
DN B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V3D178-DN
|
407
|
DN B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V3D177-DN
|
3001
|
DN B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V3D182-DN
|
3338
|
DN B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V3D190-TC
|
2644
|
CD3+ cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V3D152-TC
|
2583
|
CD3+ cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V3D163-TC
|
3536
|
CD3+ cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V3D178-TC
|
407
|
CD3+ cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V3D177-TC
|
3001
|
CD3+ cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V3D182-TC
|
3338
|
CD3+ cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V3D190-TF
|
2644
|
TFH cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V3D152-TF
|
2583
|
TFH cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V3D163-TF
|
3536
|
TFH cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V3D178-TF
|
407
|
TFH cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V3D177-TF
|
3001
|
TFH cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V3D182-TF
|
3338
|
TFH cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V3D190-PB
|
2644
|
PBMC | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V3D152-PB
|
2583
|
PBMC | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V3D163-PB
|
3536
|
PBMC | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V3D178-PB
|
407
|
PBMC | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V3D177-PB
|
3001
|
PBMC | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V3D182-PB
|
3338
|
PBMC | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V2D202-SB
|
2644
|
SARS-COV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V2D90-SB
|
2583
|
SARS-COV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V2D203-SB
|
3536
|
SARS-COV-2 Spike+ B cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V2D184-SB
|
407
|
SARS-COV-2 Spike+ B cells | SLE |
6
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO5-SLE-3001-V2D138-SB
|
3001
|
SARS-COV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO6-SLE-3338-V2D110-SB
|
3338
|
SARS-COV-2 Spike+ B cells | SLE |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO1-HD-2644-V2D202-PC
|
2644
|
Plasma cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO2-HD-2583-V2D90-PC
|
2583
|
Plasma cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO3-HD-3536-V2D203-PC
|
3536
|
Plasma cells | Healthy |
3
scRNA-seq,
CITE-seq
...
|
— | ||
|
HTO4-SLE-407-V2D184-PC
|
407
|
Plasma cells | SLE |
6
scRNA-seq,
CITE-seq
...
|
— |